Investigation on Efficacy and Safety of Apixaban in Japanese Elderly Patients: Investigator-Initiated Multicenter Prospective Cohort Study
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2016
At a glance
- Drugs Apixaban (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms J-ELD AF (CVI ARO 5)
- 14 Dec 2016 Status changed from recruiting to active, no longer recruiting.
- 30 Jun 2016 Planned End Date changed from 31 Aug 2016 to 31 Aug 2017.
- 14 Dec 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.